Live at HLTH: Revolutionizing Drug Discovery with Machine Learning—featuring Daphne Koller

The Beat · Apr 21, 2022 · 47m

Over time, drug development has become more and more challenging.

Success rates of clinical trials hover in the single digits, and the cost of developing a new treatment is greater than $2.5B.

So, what can we do to make drug discovery faster, less expensive and more successful? How might advancements in machine learning and the availability of biomedical data revolutionize the drug design process?

Daphne Koller is the CEO of Insitro, a company that is rethinking drug discovery using machine learning. She spent 18 years as a professor in the computer science department at Stanford before…